Urinary Incontinence Treatment Devices Market – Snapshot
The global urinary incontinence treatment devices market is driven by high prevalence and rapidly increasing incidence of urinary incontinence across the globe. The global market was valued at US$ 2.21 Bn in 2018 and is projected to expand at a CAGR of 7.5% from 2019 to 2027 to reach US$ 4.20 Bn by 2027. High growth of the market is attributed to increase in adoption, easy availability of electrical vaginal stimulation devices, and rise in demand for minimally invasive or non-surgical products across the globe.
Urinary incontinence is defined as involuntary release of urine due to loss of bladder control. Millions of people across the world are affected by urinary incontinence and women are more likely to be affected than men. Urinary incontinence is highly underreported primarily due to embarrassment to speak about it. Over 500 million people across the globe are affected by the condition and its incidence increases with age. Several factors such as urinary tract infection, weakening of pelvic floor muscles & urethral sphincters, menopause, pregnancy & childbirth, and post radical prostatectomy surgery in men lead to the development of urinary incontinence symptoms.
According to the International Continence Society, around 12% (both men and women) of the global geriatric population is affected by overactive bladder and its incidence increases with age. In the past few years, various treatment devices such as urethral slings, electrical stimulation devices, artificial urinary sphincters, and catheters have been developed and are increasingly used for effective management of urinary incontinence. Rise in demand for minimally invasive surgery and non-invasive treatment devices and new product launches in the electrical stimulation devices segment are projected to accelerate the growth of the global urinary incontinence treatment devices market during the forecast period.
The global urinary incontinence treatment devices market has been segmented based on product, incontinence type, end-user, and region. In terms of product, the market has been classified into urethral slings, electrical stimulation devices, artificial urinary sphincters, and catheters. The urethral slings segment has been bifurcated into female slings and male slings. The female slings sub-segment dominated the urethral slings segment in 2018. The sub-segment is projected to gain market share from 2019 to 2027. The electrical stimulation devices segment has been categorized into implantable and non-implantable. Medtronic plc’s InterStim device is the only implantable electrical simulation device available in the market for the treatment of overactive bladder symptoms.
Request Brochure of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=37196
Vaginal electrical stimulation devices are widely used and demand for these devices is increasing significantly across the globe. Urinary catheters such as Foley catheters, intermittent catheters, and external catheters dominated the global urinary incontinence treatment devices market. High adoption of Foley catheters and intermittent catheters for emptying the bladder, technologically advanced products to prevent infection, and ease of use of intermittent catheters are attributed to the large market share of the catheters segment. Based on incontinence type, the global urinary incontinence treatment devices market has been divided into stress urinary incontinence, urge urinary incontinence, mixed incontinence, and overflow incontinence. The urge incontinence segment dominated the global market in 2018. The segment is anticipated grow at a rapid pace during the forecast period.
In terms of end-user, the global urinary incontinence treatment devices market has been classified into hospitals, ambulatory surgery centers, clinics, and home use. The hospitals segment accounted for major share of the global market in 2018, followed by the ambulatory surgery centers segment. Increase in the number of multinational hospitals with advanced sling surgery techniques such TVT & TOT and adoption of mini slings are expected to boost the growth of the hospitals and ambulatory surgery centers segments during the forecast period.
Geographically, the global urinary incontinence treatment devices market has been segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America accounted for the largest share of the global market in 2018, followed by Europe. Well-established health care facilities, favorable reimbursement policies, and early adoption of technologically advanced products for the management of urinary incontinence have contributed to North America’s large market share. Europe is projected to be the most attractive market for urinary incontinence treatment devices from 2019 to 2027. The market in the region is anticipated to expand at the highest CAGR during the forecast period due to high prevalence and increase in incidence of urinary incontinence in the region, recent launch of wearable electrical stimulation devices, and high per capita health care expenditure.
The global urinary incontinence treatment devices market is consolidated, with small number of companies accounting for majority market share. Key players operating in the global market include Boston Scientific Corporation, C. R. Bard, Inc. (Becton, Dickinson and Company), Coloplast Group, Promedon Group, Medtronic plc, and Ethicon US, LLC. (Johnson & Johnson). These players exhibit significant geographical outreach, with presence in multiple urinary incontinence treatment devices segments. Manufacturers are adopting acquisition & collaboration and new product development strategies to tap the unmet needs of a large proportion of urinary incontinence patient pool. Other prominent players in the global urinary incontinence treatment devices market include ZSI Surgical Implants S.R.L., InControl Medical LLC, Hollister Incorporated, Atlantic Therapeutics Group Ltd., B. Braun Melsungen AG, A.M.I. GmbH, and Teleflex Incorporated.